Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Neurotoxicity Syndromes 1Neoplasms 1Liver Neoplasms 1Liver Cirrhosis 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 15Acupuncture Therapy 15Fentanyl 14Morphine 13Acetaminophen 13Analgesia 12Lidocaine 11Ketamine 11Bupivacaine 11Methadone 10Therapeutics 9Ropivacaine 9Psychiatric Rehabilitation 9Oxycodone 9Hydromorphone 7Saline Solution 6Radiotherapy 6Music Therapy 6Early Intervention, Educational 6Zoledronic Acid 5Yoga 5Water 5Methods 5Control Groups 5Transcutaneous Electric Nerve Stimulation 4Therapeutic Touch 4Physical Therapy Modalities 4Massage 4Ketorolac 4Exercise 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pain × Glutathione × Clear all
NCT02311907 2017-02-23

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
195 enrolled 12 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Pain, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡